IL6 and schizophrenia: Findings suggest that the relationship between IL-6 and symptom severity may vary depending on the stage of the illness (e.g., in early-onset schizophrenia (EOS), IL-6 may be neurotoxic, while in adult-onset schizophrenia (AOS), it may have a neuroprotective role), warranting cautious interpretation.